A study published in Nature Microbiology now shows for the first time that Candida auris uses a CO₂-based metabolic strategy to survive in the nutrient-poor conditions of the skin and to better tolerate antifungal therapies – especially amphotericin B (AMB).24. Dezember 2025
News SetPoint Medical secures $140M to fund neuromodulation for arthritisHealthradar12. August 2025 Listen to the article 2 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief:…
News SetPoint Medical Raises $140M to Support Commercialization of Rheumatoid Arthritis TherapyHealthradar11. August 2025 What You Should Know: – SetPoint Medical, a company focused on developing innovative therapies for chronic autoimmune diseases secures $140M…
